Author Question: A child with ALL is receiving methotrexate for therapy. Which nursing diagnosis below would best ... (Read 92 times)

Yi-Chen

  • Hero Member
  • *****
  • Posts: 550
A child with ALL is receiving methotrexate for therapy. Which nursing diagnosis below would best apply to him during therapy?
 
  A) Risk for impaired skin integrity related to oral ulcerations associated with chemotherapy
  B) Risk for impaired mobility related to depressant effects of methotrexate
  C) Excess fluid volume related to effect of methotrexate on aldosterone secretion
  D) Risk for self-directed violence related to effect of methotrexate on central nervous system

Question 2

The developmental task of the adolescent period, according to Erikson, is to form a sense of
 
  A) autonomy versus shame or doubt.
  B) initiative versus guilt.
  C) identity versus diffusion.
  D) decisiveness versus indecisiveness.



ebonylittles

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

A

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Adult head lice are gray, about ? inch long, and often have a tiny dot on their backs. A female can lay between 50 and 150 eggs within the several weeks that she is alive. They feed on human blood.

Did you know?

In 1885, the Lloyd Manufacturing Company of Albany, New York, promoted and sold "Cocaine Toothache Drops" at 15 cents per bottle! In 1914, the Harrison Narcotic Act brought the sale and distribution of this drug under federal control.

Did you know?

If all the neurons in the human body were lined up, they would stretch more than 600 miles.

Did you know?

Astigmatism is the most common vision problem. It may accompany nearsightedness or farsightedness. It is usually caused by an irregularly shaped cornea, but sometimes it is the result of an irregularly shaped lens. Either type can be corrected by eyeglasses, contact lenses, or refractive surgery.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library